Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Karyopharm Receives Orphan Drug Designation From FDA For Eltanexor For Treatment Of Myelodysplastic Syndromes


RTTNews | Jan 24, 2022 07:11AM EST

07:11 Monday, January 24, 2022 (RTTNews) - Karyopharm Receives Orphan Drug Designation From FDA For Eltanexor For Treatment Of Myelodysplastic Syndromes

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC